step 3 semaglutide Once-weekly 7·2 mg in adults with obesity (STEP UP): a randomised, controlled, phase 3b trial 🚨 STEP UP Trial: Higher-dose

Opposing studies show higher levels of SOD, such as DellAnna et al

Importantly, the platform effect for gastrointestinal and hepatobiliary side-effects proved robust: regardless of whether the full or core sample was used, TikTok consistently displayed a higher prevalence of these intuitively perceptible adverse events than Bilibili or RedNote, indicating that the platforms algorithm or audience preference amplifies the visibility of such salient toxicities

NORM UK and the medical case against circumcision

Viability was measured using the MTT assay after 24 h exposure to each compound

Phase 3 trials are ongoing

Only the research pharmacologist knew about the study groups that the patients were allocated